Location History:
- Wallingford, CT (US) (2002 - 2003)
- Madison, CT (US) (2008 - 2017)
Company Filing History:
11 out of 3,685 
2 out of 13 
1 out of 1 Years Active: 2002-2017
Title: The Innovative Contributions of Haiquan Fang
Introduction
Haiquan Fang is a renowned inventor based in Madison, CT, who has made significant contributions to the field of pharmaceuticals. With a total of 14 patents to his name, Fang has demonstrated a commitment to innovation in developing new therapeutic agents.
Latest Patents
Among his latest patents, Fang has developed a groundbreaking invention titled "Tricyclic Compounds as Anticancer Agents." This invention involves the creation of tricyclic compounds and their pharmaceutically acceptable compositions which are utilized in treating various disorders. Another notable patent is "Oxazolidinones as Modulators of mGluR5," which relates to compounds that act as ligands, agonists, and partial agonists for the mGluR5 receptor. These compounds are expected to be beneficial in addressing various central nervous system disorders.
Career Highlights
Throughout his career, Haiquan Fang has worked for prestigious organizations, including Bristol-Myers Squibb Company and the Institute for Pharmaceutical Discovery, LLC. His experiences in these companies have played a crucial role in shaping his expertise in drug discovery and development.
Collaborations
Fang has collaborated with various professionals to enhance his research and development endeavors. Notable coworkers include Matthew D. Hill and Prasad V. Chaturvedula, with whom he has shared invaluable insights and expertise in the pharmaceutical sciences.
Conclusion
Haiquan Fang's innovative work in pharmaceutical research positions him as a significant contributor to the field. His creative approach to developing new therapeutics aims to address complex health challenges, marking him as an influential figure in the realm of medical inventions.